Cross Capex To Revenue vs Total Revenue Analysis

CCRN Stock

USD 10.76 0.04 0.37%

Cross Country financial indicator trend analysis is way more than just evaluating Cross Country Healthcare prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cross Country Healthcare is a good investment. Please check the relationship between Cross Country Capex To Revenue and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Capex To Revenue vs Total Revenue

Capex To Revenue vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cross Country Healthcare Capex To Revenue account and Total Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Cross Country's Capex To Revenue and Total Revenue is -0.1. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Cross Country Healthcare, assuming nothing else is changed. The correlation between historical values of Cross Country's Capex To Revenue and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of Cross Country Healthcare are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Capex To Revenue i.e., Cross Country's Capex To Revenue and Total Revenue go up and down completely randomly.

Correlation Coefficient

-0.1

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Total Revenue

Total revenue comprises all receipts Cross Country Healthcare generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Cross Country's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cross Country Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

At this time, Cross Country's Selling General Administrative is very stable compared to the past year. As of the 29th of November 2024, Tax Provision is likely to grow to about 35.6 M, while Sales General And Administrative To Revenue is likely to drop 0.14.

	2021	2022	2023	2024 (projected)
Gross Profit	375.0M	627.7M	450.4M	472.9M
Total Revenue	1.7B	2.8B	2.0B	2.1B

Gross Profit Total Revenue

Cross Country fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Cash	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Current Deferred Revenue	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Good Will	Common Stock Total Equity	Non Current Liabilities Total	Other Current Assets	Property Plant And Equipment Gross
Total Assets		0.86	0.56	-0.05	-0.08	-0.04	0.48	0.37	0.87	0.95	0.43	0.88	0.97	0.64	0.77	0.59	0.16	0.67	0.3	0.7	0.96	0.34	0.63	0.61	0.82	0.51
Total Stockholder Equity	0.86		0.14	0.17	-0.18	0.2	0.44	0.24	0.49	0.83	-0.03	0.85	0.76	0.59	0.81	0.81	-0.18	0.65	0.48	0.54	0.8	0.29	0.67	0.13	0.75	0.61
Net Debt	0.56	0.14		-0.35	-0.24	-0.43	0.49	0.61	0.81	0.5	0.77	0.27	0.68	0.37	0.06	-0.28	0.76	0.2	-0.33	0.21	0.51	-0.09	0.32	0.79	0.22	-0.08
Cash	-0.05	0.17	-0.35		-0.1	0.97	0.18	0.01	-0.25	-0.07	-0.34	-0.14	-0.15	-0.16	0.02	0.15	-0.09	0.24	0.1	-0.03	-0.14	-0.12	0.15	-0.29	-0.2	0.02
Other Assets	-0.08	-0.18	-0.24	-0.1		-0.13	-0.81	-0.71	0.04	-0.25	0.43	-0.08	-0.15	-0.25	-0.13	0.09	-0.2	0.3	-0.02	0.33	-0.14	0.77	-0.39	0.23	0.03	-0.2
Cash And Short Term Investments	-0.04	0.2	-0.43	0.97	-0.13		0.2	0.03	-0.26	-0.01	-0.43	-0.07	-0.18	-0.15	0.15	0.29	-0.17	0.21	0.23	0.06	-0.08	-0.08	0.15	-0.31	-0.11	0.16
Common Stock Shares Outstanding	0.48	0.44	0.49	0.18	-0.81	0.2		0.92	0.4	0.61	-0.1	0.35	0.53	0.61	0.41	0.06	0.43	0.03	0.03	0.09	0.52	-0.54	0.76	0.18	0.35	0.46
Other Stockholder Equity	0.37	0.24	0.61	0.01	-0.71	0.03	0.92		0.4	0.49	0.06	0.21	0.44	0.54	0.23	-0.14	0.56	-0.04	-0.14	0.01	0.42	-0.52	0.72	0.28	0.24	0.32
Total Liab	0.87	0.49	0.81	-0.25	0.04	-0.26	0.4	0.4		0.81	0.75	0.66	0.91	0.52	0.52	0.23	0.45	0.52	0.04	0.67	0.85	0.3	0.43	0.91	0.66	0.27
Total Current Assets	0.95	0.83	0.5	-0.07	-0.25	-0.01	0.61	0.49	0.81		0.26	0.9	0.93	0.65	0.86	0.65	0.14	0.47	0.39	0.68	0.99	0.17	0.65	0.53	0.88	0.64
Short Long Term Debt Total	0.43	-0.03	0.77	-0.34	0.43	-0.43	-0.1	0.06	0.75	0.26		0.15	0.49	0.11	-0.08	-0.22	0.58	0.39	-0.33	0.39	0.34	0.43	-0.03	0.88	0.16	-0.26
Other Current Liab	0.88	0.85	0.27	-0.14	-0.08	-0.07	0.35	0.21	0.66	0.9	0.15		0.83	0.51	0.83	0.78	-0.24	0.53	0.41	0.6	0.9	0.39	0.46	0.37	0.88	0.56
Total Current Liabilities	0.97	0.76	0.68	-0.15	-0.15	-0.18	0.53	0.44	0.91	0.93	0.49	0.83		0.61	0.66	0.43	0.26	0.52	0.15	0.59	0.93	0.19	0.59	0.65	0.77	0.39
Property Plant And Equipment Net	0.64	0.59	0.37	-0.16	-0.25	-0.15	0.61	0.54	0.52	0.65	0.11	0.51	0.61		0.63	0.32	0.24	0.34	0.35	0.51	0.65	0.06	0.85	0.32	0.65	0.79
Current Deferred Revenue	0.77	0.81	0.06	0.02	-0.13	0.15	0.41	0.23	0.52	0.86	-0.08	0.83	0.66	0.63		0.86	-0.17	0.45	0.7	0.79	0.86	0.27	0.59	0.27	0.91	0.87
Retained Earnings	0.59	0.81	-0.28	0.15	0.09	0.29	0.06	-0.14	0.23	0.65	-0.22	0.78	0.43	0.32	0.86		-0.51	0.51	0.74	0.64	0.64	0.49	0.31	-0.01	0.74	0.68
Accounts Payable	0.16	-0.18	0.76	-0.09	-0.2	-0.17	0.43	0.56	0.45	0.14	0.58	-0.24	0.26	0.24	-0.17	-0.51		-0.04	-0.44	0.1	0.14	-0.27	0.23	0.56	-0.06	-0.12
Non Current Assets Total	0.67	0.65	0.2	0.24	0.3	0.21	0.03	-0.04	0.52	0.47	0.39	0.53	0.52	0.34	0.45	0.51	-0.04		0.26	0.63	0.52	0.71	0.4	0.43	0.42	0.27
Non Currrent Assets Other	0.3	0.48	-0.33	0.1	-0.02	0.23	0.03	-0.14	0.04	0.39	-0.33	0.41	0.15	0.35	0.7	0.74	-0.44	0.26		0.55	0.39	0.22	0.24	-0.07	0.42	0.71
Long Term Debt	0.7	0.54	0.21	-0.03	0.33	0.06	0.09	0.01	0.67	0.68	0.39	0.6	0.59	0.51	0.79	0.64	0.1	0.63	0.55		0.75	0.59	0.37	0.64	0.77	0.65
Net Receivables	0.96	0.8	0.51	-0.14	-0.14	-0.08	0.52	0.42	0.85	0.99	0.34	0.9	0.93	0.65	0.86	0.64	0.14	0.52	0.39	0.75		0.28	0.61	0.61	0.9	0.63
Good Will	0.34	0.29	-0.09	-0.12	0.77	-0.08	-0.54	-0.52	0.3	0.17	0.43	0.39	0.19	0.06	0.27	0.49	-0.27	0.71	0.22	0.59	0.28		-0.12	0.35	0.37	0.13
Common Stock Total Equity	0.63	0.67	0.32	0.15	-0.39	0.15	0.76	0.72	0.43	0.65	-0.03	0.46	0.59	0.85	0.59	0.31	0.23	0.4	0.24	0.37	0.61	-0.12		0.18	0.56	0.68
Non Current Liabilities Total	0.61	0.13	0.79	-0.29	0.23	-0.31	0.18	0.28	0.91	0.53	0.88	0.37	0.65	0.32	0.27	-0.01	0.56	0.43	-0.07	0.64	0.61	0.35	0.18		0.43	0.09
Other Current Assets	0.82	0.75	0.22	-0.2	0.03	-0.11	0.35	0.24	0.66	0.88	0.16	0.88	0.77	0.65	0.91	0.74	-0.06	0.42	0.42	0.77	0.9	0.37	0.56	0.43		0.75
Property Plant And Equipment Gross	0.51	0.61	-0.08	0.02	-0.2	0.16	0.46	0.32	0.27	0.64	-0.26	0.56	0.39	0.79	0.87	0.68	-0.12	0.27	0.71	0.65	0.63	0.13	0.68	0.09	0.75

Click cells to compare fundamentals

Cross Country Account Relationship Matchups

Cross Country fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	382.4M	357.0M	732.8M	947.8M	679.3M	480.8M
Total Stockholder Equity	162.6M	154.4M	297.5M	457.2M	473.4M	281.1M
Net Debt	93.9M	71.6M	194.4M	154.1M	(11.8M)	(11.2M)
Cash	1.0M	1.6M	1.0M	3.6M	17.1M	10.3M
Other Assets	18.3M	35.8M	33.5M	36.8M	33.1M	20.3M
Cash And Short Term Investments	1.0M	1.6M	1.0M	3.6M	17.1M	17.9M
Common Stock Shares Outstanding	35.8M	36.1M	37.4M	37.5M	35.5M	35.2M
Liabilities And Stockholders Equity	382.4M	357.0M	732.8M	947.8M	679.3M	480.8M
Other Stockholder Equity	305.6M	310.4M	321.6M	292.9M	236.4M	280.6M
Total Liab	218.9M	202.1M	435.3M	490.6M	205.9M	199.5M
Total Current Assets	183.4M	183.1M	508.3M	675.7M	415.2M	435.9M
Short Long Term Debt Total	94.9M	73.2M	195.5M	157.7M	5.3M	5.0M
Other Current Liab	3.6M	23.5M	70.4M	254.6M	113.3M	119.0M
Total Current Liabilities	85.5M	93.4M	199.8M	271.6M	148.6M	88.3M
Property Plant And Equipment Net	28.8M	22.8M	23.3M	22.9M	29.9M	18.0M
Current Deferred Revenue	31.3M	35.5M	72.9M	100.1M	115.1M	120.9M
Retained Earnings	(141.8M)	(154.7M)	(22.7M)	165.7M	238.4M	250.3M
Accounts Payable	45.7M	49.9M	109.8M	12.9M	3.0M	2.9M
Non Current Assets Total	199.0M	173.9M	224.5M	272.2M	264.2M	201.9M
Non Currrent Assets Other	18.3M	(17.4M)	7.3M	10.4M	38.4M	40.3M
Long Term Debt	71.0M	53.4M	176.4M	148.7M	171.0M	179.6M
Net Receivables	174.5M	174.7M	499.0M	660.0M	388.3M	407.8M
Good Will	101.1M	90.9M	119.5M	163.3M	135.4M	128.7M
Non Current Liabilities Total	133.4M	108.6M	235.5M	219.0M	57.3M	110.7M
Other Current Assets	1.7M	6.8M	8.3M	12.1M	9.7M	10.2M
Property Plant And Equipment Gross	28.8M	22.9M	23.3M	22.9M	45.7M	48.0M
Accumulated Other Comprehensive Income	(1.2M)	(1.3M)	(1.3M)	(1.4M)	(1.4M)	(1.5M)
Short Term Debt	4.9M	6.9M	12.4M	4.1M	5.2M	6.6M
Intangible Assets	50.9M	40.7M	48.2M	44.7M	54.5M	95.4M
Property Plant Equipment	11.8M	12.4M	23.3M	19.7M	22.6M	15.9M
Other Liab	43.4M	40.0M	48.3M	65.4M	75.2M	78.9M
Inventory	6.1M	5.5M	7.6M	11.1M	10.0M	10.1M
Net Tangible Assets	10.7M	22.7M	129.8M	412.5M	474.4M	498.1M
Noncontrolling Interest In Consolidated Entity	630K	670K	868K	534K	614.1K	463.2K
Retained Earnings Total Equity	(141.8M)	(154.7M)	(22.7M)	165.7M	190.6M	200.1M
Long Term Debt Total	71.0M	53.4M	176.4M	148.7M	171.0M	179.6M

Pair Trading with Cross Country

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cross Country position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cross Country will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cross Stock

0.77

Cigna Corp

Pair Corr

Moving against Cross Stock

0.87	ECOR	Electrocore LLC	Pair Corr
0.85	MD	Mednax Inc	Pair Corr
0.79	DOCS	Doximity Sell-off Trend	Pair Corr
0.74	VREX	Varex Imaging Corp	Pair Corr
0.7	OM	Outset Medical	Pair Corr

The ability to find closely correlated positions to Cross Country could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cross Country when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cross Country - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cross Country Healthcare to buy it.

The correlation of Cross Country is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cross Country moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cross Country Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Cross Country can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Cross Country Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cross Country's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cross Country Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cross Country Healthcare Stock:

How To Invest In Cross

Details

Is Cross Stock a good investment?

Details

What is Cross Country's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cross Country. If investors know Cross will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cross Country listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.79)

Earnings Share

(0.05)

Revenue Per Share

42.699

Quarterly Revenue Growth

(0.29)

Return On Assets

0.0127

The market value of Cross Country Healthcare is measured differently than its book value, which is the value of Cross that is recorded on the company's balance sheet. Investors also form their own opinion of Cross Country's value that differs from its market value or its book value, called intrinsic value, which is Cross Country's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cross Country's market value can be influenced by many factors that don't directly affect Cross Country's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cross Country's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cross Country is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cross Country's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cross Capex To Revenue vs Total Revenue Analysis

Capex To Revenue vs Total Revenue

Capex To Revenue vs Total Revenue Correlation Analysis

Correlation Coefficient

Capex To Revenue

Total Revenue

Cross Country fundamental ratios Correlations

Cross Country Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cross Country fundamental ratios Accounts

Pair Trading with Cross Country

Moving together with Cross Stock

Moving against Cross Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Receivables	+ 0.99	Total Current Assets
Total Current Liabilities	+ 0.97	Total Assets
Cash And Short Term Investments	+ 0.97	Cash
Net Receivables	+ 0.96	Total Assets
Total Current Assets	+ 0.95	Total Assets
Total Current Liabilities	+ 0.93	Total Current Assets

Common Stock Shares Outstanding	- 0.81	Other Assets
Other Stockholder Equity	- 0.71	Other Assets
Good Will	- 0.54	Common Stock Shares Outstanding
Good Will	- 0.52	Other Stockholder Equity
Accounts Payable	- 0.51	Retained Earnings
Non Currrent Assets Other	- 0.44	Accounts Payable